跳至主要内容
临床试验/NCT02764320
NCT02764320已完成不适用

Determining the Optimal Treatment Strategy for Patients Who Have Chronic Migraine With Medication Overuse

Mayo Clinic29 个研究点 分布在 1 个国家目标入组 720 人开始时间: 2017年1月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
720
试验地点
29
主要终点
Frequency of Moderate to Severe Headache Days

研究概览

简要总结

There are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse. This study will compare the outcomes amongst patients randomized to one of the two treatment strategies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults, at least 21 years of age
  • •Chronic Migraine - diagnosed according to ICHD3beta criteria
  • •Medication Overuse - diagnosed according to ICHD3beta criteria
  • •Willingness to be randomized to either of the two treatment arms
  • •Willingness to maintain a headache diary
  • •Plan for follow-up care with the clinician
  • •No changes to migraine prophylactic therapy within the 4 weeks prior to randomization.

排除标准

  • •Younger than 21 years of age
  • •Headache diagnoses other than chronic migraine with medication overuse; episodic tension-type headache on 3 or fewer days per month is allowed
  • •Not willing to be randomized to either of the treatment arms
  • •Not willing to maintain a daily headache diary
  • •Not planning on follow-up care with the clinician
  • •In the opinion of the clinician, randomization to either treatment arm would be considered unsafe (ex: pregnancy, immediate discontinuation
  • •Prisoners
  • •Diminished decision-making capacity which in the investigator's opinion would interfere with the person's ability to provide informed consent and complete study procedures.

研究组 & 干预措施

Discontinuation

Active Comparator

Migraine prophylactic therapy will be initiated or optimized with the immediate discontinuation of the overused medication(s)

干预措施: Discontinuation of Overused Medication (Other)

Preventive Therapy Only

Active Comparator

Migraine prophylactic therapy will be initiated or optimized without the early discontinuation of the overused medication(s)

干预措施: Migraine Prophylactic Therapy Only (Other)

结局指标

主要结局

Frequency of Moderate to Severe Headache Days

时间窗: 12 weeks

Number of days on which a headache lasts for at least 2 hours and at any time peaks at moderate or severe intensity

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Todd J. Schwedt

PI

Mayo Clinic

研究点 (29)

Loading locations...

相似试验